Newton-based Thermalin plans human tests of concentrated insulin next year By: Boston Business Journal via Business Journals July 28, 2014 at 12:51 PM EDT As the number of diabetics worldwide skyrockets, a small Newton company developing new types of insulin has closed on $1... Read More >> Related Stocks: Eli Lilly Merck & Co Novo Nordisk A/S ADR Sanofi-Aventis S.A. ADR